21180 ⎘
Medicinal preparations containing antigens or antibodies characterised by the route of administration; Mucosal route oral/gastrointestinal
CLINICALLY PROVEN SUBCUTANEOUS PHARMACEUTICAL COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND THEIR USES IN COMBINATION WITH POMALIDOMIDE AND DEXAMETHASONE
#2ANTIBODY BASED TREATMENT TO REDUCE GUT BACTERIAL GLYCAN AND ASSOCIATED BACTERIA
#3COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
#4Methods, compositions and therapeutical vaccine for autoimmune diseases and allergy treatment
#5UNIVERSAL T CELL-BASED, CMV-VECTORED VACCINE FOR INFLUENZA
#6PIV5-BASED COVID-19 VACCINE
#7ORAL VACCINE FOR ENHANCING CANCER IMMUNOTHERAPY
#8SYSTEMS AND METHODS FOR PRODUCING ANTIBODIES
#9THERMOSTABLE MUCOSAL VACCINE COMPOSITIONS AND METHODS
#10COMPOSITIONS, KITS, METHODS, AND METHODS OF ADMINISTRATION RELATING TO EDWARDSIELLA PISCICIDA VACCINE AND/OR ANTIGEN DELIVERY VECTOR SYSTEMS
#11SUBLINGUAL TABLET AND APPLICATION THEREOF IN DESENSITIZATION THERAPY DRUG
#12CULTURE METHOD FOR FISH CELLS AND CELL CULTURE MEDIUM USED THEREIN, AND ORAL VACCINE FOR FISH
#13Methods For Reducing Or Preventing Cerebral Edema After Stroke
#14PEANUT FORMULATIONS AND USES THEREOF
#15COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
#16VACCINE AGAINST CAMPYLOBACTER JEJUNI
#17IMMUNOGENIC GEL COMPOSITIONS
#18Device for Collecting Airborne Allergens in Water
#19RECOMBINANT FLAVOBACTERIUM COVAE PROTEIN VACCINES
#20METHODS FOR PREVENTING FOOD SENSITIZATION
#21AQUATIC FEED PELLETS AND METHOD OF PREPARATION
#22NOVEL VACCINES FOR TUBERCULOSIS
#23CANCER IMMUNOTHERAPY ORAL VACCINE
#24VACCINE COMPOSITION
#25ORAL VACCINE COMPOSITION
#26PIV5-BASED COVID-19 VACCINE
#27ENGINEERED BISPECIFIC MOLECULES AND METHODS OF USE
#28ENGINEERED BISPECIFIC MOLECULES AND METHODS OF USE
#29M-cell GP2-mediated lymphatic-targeted drug carriers
#30TARGETED ANTI-SGLT1 AVIAN IGY ANTIBODIES AS TREATMENT OF PRE-DIABETES, TYPE 2 DIABETES AND GESTATIONAL DIABETES
#31METHOD FOR ENHANCING IMMUNITY
#32LIVE ATTENUATED SARS-COV-2 AND A VACCINE MADE THEREOF
#33Method for Obtaining SARS-CoV-2 Aerosol Variants for Oral Vaccines Inducing Gut-based Immunity Against COVID-19
#34Larygotracheitis Virus (LT) Vector Vaccines for use with Avian Respiratory Pathogens
#35IMMUNOSTIMULATORY PREPARATION AND COSMETIC, FOOD, FEED ADDITIVE, AND QUASI-PHARMACEUTICAL PRODUCT CONTAINING THE IMMUNOSTIMULATORY PREPARATION
#36MULTIVALENT ANTI-CAMPYLOBACTER ANTIBODIES AND VACCINE
#37POLYSACCHARIDES FOR USE IN TREATING SARS-COV-2 INFECTIONS
#38ARTHROSPIRA PLATENSIS ORAL VACCINE DELIVERY PLATFORM
#39DUAL AND TRIPLE HAPTEN CONJUGATES, COMPOSITIONS, PROCESSES FOR MAKING, AND METHODS OF TREATMENT THEREWITH
#40TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION
#41GENE DELIVERY SYSTEM
#42USTEKINUMAB DOSAGE FORMS AND METHODS
#43MUCOSAL ADMINISTRATION METHODS AND FORMULATIONS
#44LIVE MYCOPLASMA GALLISEPTICUM VACCINES
#45RESPIRATORY SYNCYTIAL VIRUS RECOMBINANT FUSION PROTEIN WITH PRE-FUSION CONFORMATION, PREPARATION METHOD AND USES THEREOF
#46CO-EXPRESSION OF CONSTRUCTS AND IMMUNOSTIMULATORY COMPOUNDS
#47PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS
#48COMPOSITIONS AND METHODS
#49Engineered Probiotic Delivery System for Anti-SARS-COV-2 Treatment and Immunity Against Viruses
#50PREPARATION OF LIVE VACCINES
#51METHODS AND COMPOSITIONS FOR VACCINATION AGAINST HETEROSUBTYPIC INFLUENZA VIRUSES USING AN ADENOVIRAL VECTOR LEADING TO ENHANCED T CELL RESPONSE THROUGH AUTOPHAGY
#52TETANUS VACCINE PLATFORM FOR EMBEDDING COVID-19 VACCINE
#53CONCATEMERIC PEPTIDE EPITOPE RNAS
#54Immunogenic Fusion Peptides Including FC Fragment and a Non Toxic B Subunit of AB5 Toxin
#55EXPRESSION OF BORRELIA BURGDORFERI OUTER SURFACE PROTEIN A IN PLANTS AND PLANT PRODUCED VACCINE FOR SAME
#56FORMULATIONS FOR SMALL INTESTINAL DELIVERY
#57NOVEL ANTI-IL-36R ANTIBODIES
#58COMPOSITIONS AND METHODS FOR FOOD ALLERGY PREVENTION
#59COMPOSITIONS AND METHODS FOR USE IN IMMUNOTHERAPY
#60ORAL THERAPEUTIC VACCINE COMPOSITIONS, METHODS AND TREATMENT OF COVID
#61ALKALINE EXTRACTION OF BETA GLUCAN COMPOUNDS FOR USE IN ANTI-VIRAL AND IMMUNE THERAPIES
#62METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS
#63IMMUNOMODULATING TRANSGENIC PLANTS AND RELATED METHODS
#64METHODS AND COMPOSITIONS FOR ORALLY DOSING ANIMALS
#65Vaccine Compositions For Preventing Coronavirus Disease
#66MUCOADHESIVE-PLGA NANOPARTICLES
#67VIRUS
#68ALLERGY TREATMENT
#69ANTIBODY-INDUCING POLYPEPTIDE AND VACCINE
#70Compositions and Methods For Reducing Immune Intolerance and Treating Autoimmune Disorders
#71VACCINE FOR PREVENTING AFRICAN SWINE FEVER, COMPRISING AFRICAN SWINE FEVER VIRUS-DERIVED ANTIGEN PROTEIN
#72ORAL VACCINE VIA DENTAL BACTERIA AND EMITTED PEPTIDES TO PREVENT INFECTION FROM A PATHOGEN
#73SYNERGISM OF IMMUNOGENICITY VIA COMBINED PARENTERAL AND MUCOSAL IMMUNIZATION AGAINST COVID-19
#74GUT BACTERIA DERIVED MICROVESICLES FOR VACCINE DELIVERY
#75COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE
#76VACCINE FOR PROTECTION AGAINST ETEC-INDUCED DIARRHEA COMPRISING DMLT
#77NOVEL CORONAVIRUS VACCINE BASED ON CONTROLLABLE SECRETORY EXPRESSION OF ATTENUATED SALMONELLA, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#78MICROENCAPSULATED STERNE VACCINE
#79COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
#80Composition for inducing proliferation or accumulation of regulatory T cells
#81VACCINE METHOD AND COMPOSITION FOR BACTERIAL DISEASES IN INVERTEBRATES
#82Attenuated Porcine Epidemic Diarrhea Virus
#83COMPOSITIONS AND METHODS FOR TREATING CANCER
#84COMPOSITIONS
#85GENETICALLY MODIFIED CLOSTRIDIUM STRAINS EXPRESSING RECOMBINANT ANTIGENS AND USES THEREOF
#86Toothpaste for Delivery of Allergens to Oral Mucosa
#87ORAL VACCINE VIA DENTAL BACTERIA AND EMITTED PEPTIDES TO PREVENT COVID-19 INFECTION
#88Composition for Oral or Nasal Delivery of Tetanus, Diphtheria, and Pertussis Vaccine alone or in combination using Neurotoxin Associated Proteins
#89PERIODONTITIS VACCINE AND RELATED COMPOSITIONS AND METHODS OF USE
#90METHODS OF TREATING ALLERGIES
#91Composition for the treatment of antibody deficiencies
#92IMMUNOMODULATING TRANSGENIC PLANTS AND RELATED METHODS
#93ORAL COMPOSITIONS AND USE OF SAME IN VACCINATION
#94SALMONELLA VACCINE
#95Personalized Site-Specific Immunomodulation
#96ORAL VACCINE COMPOSITION
#97PREPARATION OF LIVE VACCINES
#98TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION
#99IMMUNOSTIMULATORY AGENTS IN COMBINATION WITH ANGIOGENESIS INHIBITORS
#100APPARATUS FOR DETERMINING ADMINISTRATION FORM OF A COMPOSITION OF AN ENGINEERED VIRUS-BASED NANOPARTICLE FOR A TREATMENT OF AN AUTOIMMUNE CONDITION
#101Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins
#102Periodontitis vaccine and related compositions and methods of use
#103Attenuating bacterial virulence by attenuating bacterial folate transport
#104Active Agent Delivery Devices and Methods of Using the same
#105OPTIMIZED HOST/VECTOR SYSTEM FOR PRODUCING PROTECTIVE MONO- AND MULTIVALENT SUBUNIT VACCINES ON THE BASIS OF THE YEAST KLUYVEROMYCES LACTIS
#106Compositions and methods for the treatment of type 1 diabetes
#107COMPOSITIONS AND METHODS
#108YEAST-BASED EXPRESSION OF THERAPEUTIC PROTEINS IN VIVO
#109Fluorocarbon-Linked Peptide Formulation
#110SYSTEMS FOR BUCCAL RELEASE OF PROTEINS
#111DECTIN-1 (CLEC7A) SINGLE NUCLEOTIDE POLYMORPHISM AS A BIOMARKER FOR PREDICTING ANTIBODY RESPONSE WHEN USING BETA-GLUCAN AS A VACCINE ADJUVANT
#112TREATMENT REGIMEN FOR CANCER USING IMMUNOMODULATION
#113IMMUNOGENIC COMPOSITIONS COMPRISING LAWSONIA INTRACELLULARIS
#114Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Pomalidomide and Dexamethasone
#115METHODS OF MANUFACTURE OF NUT FLOURS AND FORMULATIONS FOR ORAL IMMUNOTHERAPY
#116MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME
#117Tetanus vaccine platform for embedding COVID-19 vaccine
#118Composition for diagnosis and treatment of alcoholic liver disease, using change in short-chain fatty acid producing gut bacterial community
#119ANTI-INTERLEUKIN ANTIBODY PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
#120WT1 TARGETING DNA VACCINE FOR COMBINATION THERAPY
#121COMPOSITIONS FOR TREATING AND/OR PREVENTING CORONAVIRUS INFECTIONS
#122IMMUNOGENIC GEL COMPOSITIONS
#123Method to reduce tick population with a universal tick antigen
#124SALMONELLA-BASED DNA VACCINES IN COMBINATION WITH AN ANTIBIOTIC
#125MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION
#126Methods of vaccine administration
#127Protection from stress, anxiety, neuroinflammation, and cognitive dysfunction
#128Polypeptides comprising immunoglobulin chain variable domains which bind to interleukin-6 receptor (IL-6R) and methods of use thereof to treat autoimmune and inflammatory diseases
#129PEPTIDE ANTIGENS AND USES THEREOF
#130METHODS OF ORAL IMMUNOTHERAPY
#131Compositions and methods of enhancing immune responses to or limiting infection
#132Immunomodulating transgenic plants and related methods
#133Dosage regimes for the administration of an anti-CD19 ADC
#134METHODS AND ARTICLES FOR ALLERGIC DESENSITIZATION VIA THE ORAL MUCOSA
#135FILM WITH LATERALLY ADJOINED STRIPS FOR ADMINISTRATION OF A VACCINE
#136DRUG DELIVERY COMPOSITION
#137Attenuating bacterial virulence by attenuating bacterial folate transport
#138METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INDUCING IMMUNE TOLERANCE BY MUCOSAL VACCINATION WITH FC-COUPLED ANTIGENS
#139Single cycle replicating adenovirus vectors
#140CONCATEMERIC PEPTIDE EPITOPE RNAS
#141MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME
#142Gut bacteria derived microvesicles for vaccine delivery
#143COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
#144Preparation of live vaccines
#145Compositions and methods for induction of Th17 cells
#146METHODS OF INTRODUCING FOOD ALLERGENS
#147Alphavirus nsP mutants as vaccines
#148COMPOSITION AND METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES
#149Composition for the treatment of antibody deficiencies
#150Pharmaceutical composition comprising attenuated strains and use thereof
#151Periodontitis vaccine and related compositions and methods of use
#152Immunostimulatory agents in combination with angiogenesis inhibitors
#153Replication-competent attenuated chimeric VSV vectors encoding immunogenic SARS-CoV-2 spike proteins
#154Vaccine for protection against ETEC-induced diarrhea comprising dmLT
#155ORAL VACCINES EXPRESSED IN YEAST FOR COVID-19
#156Polypeptides
#157Malaria transmission blocking vaccine
#158Induction of protective immunity against antigens
#159Antibodies against species
#160Protection from stress, anxiety, neuroinflammation, and cognitive dysfunction
#161Mixed allergen compositions and methods for using the same
#162Poultry vaccine for clostridium perfringens
#163Optimized host/vector system for producing protective mono- and multivalent subunit vaccines on the basis of the yeast
#164ARTHROSPIRA PLATENSIS ORAL VACCINE DELIVERY PLATFORM
#165Gel delivery system for treating poultry
#166Toothpaste for delivering allergens to oral mucosa
#167Compositions and methods for the treatment of type 1 diabetes
#168Live attenuated Arkansas serotype infectious bronchitis virus vaccine
#169Nanoparticle compositions for vaccines
#170Combined cancer therapy with immune checkpoint modulators and fermentation products by symbiotic microbiota
#171COMPOSITIONS COMPRISING BACTERIAL STRAINS
#172Method for reducing zoonotic infectious diseases
#173Anti-cancer plant virus particles linked to HER2 antigens
#174Vaccine treatment and control infectious against viral pathogens utilizing heparan sulfate (HS) as cellular receptor
#175ADJUVANT SYSTEM FOR ORAL VACCINE ADMINISTRATION
#176Peanut formulations and uses thereof
#177Tuberculosis vaccine, preparation method therefor, and use thereof
#178Fluorocarbon-linked peptide formulation
#179Compositions and methods for treating cancer and promoting wound healing
#180Immunogenic compositions comprising
#181Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
#182Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection
#183Mucosal adjuvants and delivery systems
#184Coccidiosis vaccine
#185Active agent delivery devices and methods of using the same
#186Methods of vaccine administration
#187Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#188Mixed allergen compositions and methods for using the same
#189Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
#190Polypeptides which bind to interleukin-6 receptor (IL-6R)
#191Pollen grains for treatment of peanut and other allergies
#192Vaccine composition for classical swine fever and preparation method thereof
#193Pharmaceutical composition comprising attenuated strains and use thereof
#194Bacterial protein compositions and uses thereof
#195Biofilm matrix-boosted vaccine
#196Single cycle replicating adenovirus vectors
#197Non-toxigenic spores for use in oral vaccination
#198Compositions and methods for the induction of CD8+ T-cells
#199PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#200Nanoparticles for treatment of allergy
#201Composition for inducing proliferation or accumulation of regulatory T cells
#202Vaccine for protection against ETEC-induced diarrhea comprising dmLT
#203Rabbit coccidiosis vaccine and application thereof
#204Dosage regimes for the administration of an anti-CD19 ADC
#205Mixed allergen compositions and methods for using the same
#206Immunotherapy for the treatment of allergic disease
#207VACCINES AGAINST TICK-BORNE DISEASES
#208METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INDUCING IMMUNE TOLERANCE BY MUCOSAL VACCINATION WITH FC-COUPLED ANTIGENS
#209Manufacture of peanut formulations for oral desensitization
#210Personalized Site-Specific Immunomodulation
#211Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#212Compositions and methods for the induction of CD8+ T-cells
#213Immunomodulating transgenic plants and related methods
#214Toothpaste for delivery of allergens to oral mucosa
#215VEGFR-2 targeting immunotherapy approach
#216Compositions and methods of use of interleukin-10 peptides and anti-interleukin-10 antibodies
#217ORAL COMPOSITION AND METHODS FOR IMMUNOTHERAPY
#218Single cycle replicating adenovirus vectors
#219Induction of protective immunity against antigens
#220Mixed allergen compositions and methods for using the same
#221Oral vaccine against ruminant respiratory disease comprising polyvinylpyrrolidone
#222Compositions and methods for the induction of CD8+ T-cells
#223Mixed allergen compositions and methods for using the same
#224Alphavirus NSP mutants as vaccines
#225Cancer therapy utilizing combination of oral tumor vaccine and immunosuppression inhibitor
#226Virus
#227Compositions and methods for the induction of CD8+ T-cells
#228Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
#229Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
#230Compositions
#231Composition for enhancing induction of humoral immunity, and vaccine pharmaceutical composition
#232Compositions and methods of enhancing immune responses to or limiting infection
#233COMPOSITIONS AND METHODS FOR INDUCTION OF TH17 CELLS
#234Composition for inducing proliferation or accumulation of regulatory T cells
#235Composition for inducing proliferation or accumulation of regulatory T cells
#236LIQUID ALLERGEN COMPOSITIONS AND METHODS FOR MAKING THE SAME
#237Mucosal adjuvants and delivery systems
#238Compositions of food allergens
#239Transgenic VERO-CD4/CCR5 cell line
#240Recombinant protein delivered as nanoparticles
#241Tobacco products
#242Feed additive composition for immunoprotection of fish against infectious viral species
#243Composition for oral delivery of bioactive agents
#244Codon optimization for increasing transgene expression in chloroplasts of higher seed plants
#245Microparticulated Vaccines for the Oral or Nasal Vaccination and Boostering of Animals Including Fish
#246Peanut formulations and used thereof
#247Periodontitis vaccine and related compositions and methods of use
#248Compositions
#249Peanut formulations and uses thereof
#250COMPOSITION FOR DELIVERY OF ACTIVE AGENTS TO AN ANIMAL
#251Methods of oral immunotherapy
#252Biomolecule preservation
#253Live attenuated vaccine and method of using the same
#254Buffer free, acid stable low dose volume rotavirus vaccine
#255Immunogenic compositions comprising
#256Compositions and methods for treating cancer and promoting wound healing
#257Single cycle replicating adenovirus vectors
#258Polypeptides Having Immunoactivating Activity And Methods Of Producing The Same
#259Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins
#260Treatment of immune disease by mucosal delivery of antigens using genetically modified
#261Stable aqueous formulations of adalimumab
#262Stable aqueous formulations of adalimumab
#263Stable aqueous formulations of adalimumab
#264PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#265Stable aqueous formulations of adalimumab
#266Mixed allergen compositions and methods for using the same
#267Mixed allergen compositions and methods for using the same
#268Immunotherapy for the treatment of allergic disease
#269Alginate chitosan nanoformulation of OmpA—a protein subunit
#270Gel for treating infectious bronchitis
#271Composition for inducing proliferation or accumulation of regulatory T cells
#272Vaccination using plant virus particles linked to HER2 antigens
#273Composition for inducing proliferation or accumulation of regulatory T cells
#274METHODS TO INCREASE ANTIGENICITY OF MEMBRANE-BOUND POLYPEPTIDES PRODUCED IN PLANTS
#275Compositions and methods for the treatment of type 1 diabetes
#276Live bacterial vectors for prophylaxis or treatment
#277Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants
#278Vaccine strains of brachyspira hyodysenteriae
#279Concatemeric peptide epitope RNAs
#280DNA vaccine for use in pancreatic cancer patients
#281Thermally stable rotavirus vaccine formulations and methods of use thereof
#282Use of polyclonal antibodies against clostridium difficile for treatment of inflammatory bowel disease
#283METHOD, COMPOSITION & APPARATUS FOR THE TREATMENT OF TYPE I ALLERGIC HYPERSENSITIVITIES BY IMMUNE DESENSITIZATION THROUGH SLIT IMMUNOTHERAPY WITH UNADULTERATED ALLERGEN, VITAMIN A AND VITAMIN D
#284Recombinant lactic acid bacteria and the use thereof in oral universal influenza vaccine
#285Vaccine pharmaceutical composition for oral administration and method for manufacturing vaccine pharmaceutical composition for oral administration
#286Stable aqueous formulations of adalimumab
#287Stable aqueous formulations of adalimumab
#288Stable aqueous formulations of adalimumab
#289Stable aqueous formulations of adalimumab
#290Mammalian milk osteopontin for enhancing immune responsiveness
#291METHOD FOR THE PRODUCTION OF HYDROLYZED ALLERGEN
#292Non-toxigenic spores for use in oral vaccination
#293Compositions comprising bacterial strains
#294Heat stable liquid rotavirus vaccine
#295Live attenuated Arkansas serotype infectious bronchitis virus vaccine
#296Methods and pharmaceutical compositions for inducing immune tolerance by mucosal vaccination with Fc-coupled antigens
#297METHODS OF MANUFACTURE OF NUT FLOURS AND FORMULATIONS FOR ORAL IMMUNOTHERAPY
#298COMPOSITION FOR DELIVERY OF ACTIVE AGENTS TO AN ANIMAL
#299Soft gel delivery method for treating poultry
#300ALLERGY-SPECIFIC IMMUNOTHERAPY COMPOSITIONS FOR USE IN THE TREATMENT OF HOUSE-DUST MITE ALLERGY